Ultragenyx Pharmaceutical Inc (RARE)
43.48
+0.12
(+0.29%)
USD |
NASDAQ |
Apr 19, 09:48
Ultragenyx Pharmaceutical Market Cap: 3.580B for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 3.569B |
| April 17, 2024 | 3.632B |
| April 16, 2024 | 3.484B |
| April 15, 2024 | 3.530B |
| April 12, 2024 | 3.870B |
| April 11, 2024 | 4.174B |
| April 10, 2024 | 4.249B |
| April 09, 2024 | 4.163B |
| April 08, 2024 | 4.136B |
| April 05, 2024 | 4.137B |
| April 04, 2024 | 3.876B |
| April 03, 2024 | 3.876B |
| April 02, 2024 | 3.836B |
| April 01, 2024 | 3.867B |
| March 28, 2024 | 3.844B |
| March 27, 2024 | 3.855B |
| March 26, 2024 | 3.743B |
| March 25, 2024 | 3.740B |
| March 22, 2024 | 3.775B |
| March 21, 2024 | 3.841B |
| March 20, 2024 | 3.871B |
| March 19, 2024 | 3.870B |
| March 18, 2024 | 3.836B |
| March 15, 2024 | 3.900B |
| March 14, 2024 | 3.841B |
| Date | Value |
|---|---|
| March 13, 2024 | 3.997B |
| March 12, 2024 | 3.924B |
| March 11, 2024 | 3.994B |
| March 08, 2024 | 4.160B |
| March 07, 2024 | 4.187B |
| March 06, 2024 | 4.221B |
| March 05, 2024 | 4.238B |
| March 04, 2024 | 4.389B |
| March 01, 2024 | 4.421B |
| February 29, 2024 | 4.258B |
| February 28, 2024 | 4.343B |
| February 27, 2024 | 4.418B |
| February 26, 2024 | 4.137B |
| February 23, 2024 | 4.074B |
| February 22, 2024 | 4.025B |
| February 21, 2024 | 3.967B |
| February 20, 2024 | 3.941B |
| February 16, 2024 | 4.028B |
| February 15, 2024 | 3.809B |
| February 14, 2024 | 3.759B |
| February 13, 2024 | 3.620B |
| February 12, 2024 | 3.847B |
| February 09, 2024 | 3.847B |
| February 08, 2024 | 3.741B |
| February 07, 2024 | 3.680B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.957B
Minimum
Mar 16 2020
11.74B
Maximum
Dec 23 2020
4.407B
Average
3.686B
Median
Aug 08 2022
Market Cap Benchmarks
| Corcept Therapeutics Inc | 2.350B |
| Madrigal Pharmaceuticals Inc | 4.457B |
| Sarepta Therapeutics Inc | 11.00B |
| Rocket Pharmaceuticals Inc | 2.120B |
| Apellis Pharmaceuticals Inc | 5.749B |
Market Cap Related Metrics
| PS Ratio | 7.362 |
| Price to Book Value | 13.00 |
| Price | 43.48 |
| Earnings Yield | -19.16% |